Skip to main content

previous disabled Page of 2
and
  1. No Access

    Chapter

    Therapy Regimens Used in Adjuvant and Neoadjuvant Treatment of the Discussed Tumor Types

    K. Possinger, A. Schauer, F. Griesinger, A. C. Roever in The Sentinel Lymph Node Concept (2005)

  2. No Access

    Article

    Orbital metastases in breast cancer: report of two cases and review of the literature

    Intraorbital metastases of solid tumors are a rarely diagnosed clinical condition, even though pathological reports suggest an incidence of up to 30% in cancer patients. We report two cases of intraorbital, ex...

    A. Dieing, C.-O. Schulz, P. Schmid in Journal of Cancer Research and Clinical On… (2004)

  3. No Access

    Article

    Primary chemotherapy with doxorubicin and paclitaxel in patients with early breast cancer: final results of a multicenter phase II study

    To assess the efficacy and safety of primary systemic treatment with doxorubicin and paclitaxel in patients with early breast cancer.

    P. Schmid, J. Krocker, G. Morack in Journal of Cancer Research and Clinical On… (2004)

  4. No Access

    Chapter

    Mammakarzinom

    Das Mammakarzinom stellt mit etwa 23% aller malignen Erkrankungen den häufigsten Tumor der Frau dar, an dem in der westlichen Zivilisation derzeit jede achte bis jede zehnte Frau im Lauf ihres Lebens erkrankt....

    C. Zielinski, K. Possinger, M. Kiechle in Die Onkologie (2004)

  5. No Access

    Chapter

    Pankreaskarzinom

    Der Anteil der Pankreaskarzinome an allen malignen Neoplasien ist 2-3%. Die Inzidenz liegt bei 7-8/100.000 für Frauen und 10-11/100.000 bei Männern. Das Verhältnis erkrankter Frauen zu Männer ist bei unter 40-...

    E. Späth-Schwalbe, G. Fortnagel, D. Lüftner, H. G. Beger in Geriatrische Onkologie (2002)

  6. No Access

    Chapter

    Hochmaligne Non-Hodgkin-Lymphome (NHL)

    Die hochmalignen NHL sind eine heterogene Gruppe von Erkrankungen, deren gemeinsames biologisches Merkmal ein aggressives klinische Verhalten ist. Das heißt, dass die Erkrankungen in der Regel rasch fortschrei...

    E. Späth-Schwalbe, K. Possinger in Geriatrische Onkologie (2002)

  7. No Access

    Article

    Relationship between bone marrow angiogenesis and plasma cell infiltration and serum β2-microglobulin levels in patients with multiple myeloma

    There is growing evidence that angiogenesis is important not only in solid tumors but also in hematological malignancies. Recently, we found that bone marrow angiogenesis is a prognostic factor for disease-re...

    O. Sezer, K. Niemöller, C. Jakob, I. Zavrski, U. Heider, J. Eucker in Annals of Hematology (2001)

  8. No Access

    Article

    Coincidence of Gaucher's disease due to a 1226G/1448C mutation and of an immunoglobulin G lambda multiple myeloma with Bence-Jones proteinuria

     We report about a 58-year-old female with coexisting type-I Gaucher's disease (GD) and multiple myeloma (MM). The diagnosis of GD was made in early childhood by means of bone marrow biopsy and was recently co...

    H. Harder, J. Eucker, C. Zang, K. Possinger, J. Müller-Höcker in Annals of Hematology (2000)

  9. No Access

    Article

    Patients with malignant lymphomas experience a higher rate of documented infections than patients with breast cancer after high-dose chemotherapy with autologous peripheral stem cell transplantation

     The influence of underlying disease on documented infections has rarely been addressed in patients treated with high-dose chemotherapy (HDCT) and subsequent autologous peripheral blood stem cell transplantati...

    O. Sezer, J. Eucker, C. Bauhuis, M. Schweigert, D. Lüftner in Annals of Hematology (2000)

  10. No Access

    Article

    Bone marrow microvessel density is a prognostic factor for survival in patients with multiple myeloma

     The importance of neoangiogenesis for the progressive growth and viability of solid tumors is well established. Recently, there has been growing evidence that angiogenesis might also be important in hematolog...

    O. Sezer, K. Niemöller, J. Eucker, C. Jakob, O. Kaufmann in Annals of Hematology (2000)

  11. No Access

    Article

    Primary hepatic or splenic diffuse large B-cell lymphoma and hepatitis C virus infection: a non-fortuitous association?

    I. Genvresse, E. Späth-Schwalbe, H. Meisel, O. Kaufmann in Annals of Hematology (2000)

  12. No Access

    Article

    Further evidence for oxidant-induced vascular endothelial growth factor up-regulation in the bronchoalveolar lavage fluid of lung cancer patients undergoing radio-chemotherapy

    Background: Vascular endothelial growth factor (VEGF) is a potent inducer of physiological and neoplastic blood vessel growth. Moreover, in vitro studies have demonstrated that VEGF can be up-regulated by condit...

    T. Beinert, D. Binder, C. Oehm, S. Ziemer in Journal of Cancer Research and Clinical On… (2000)

  13. No Access

    Article

    An unusual case of leukemic non-Hodgkin's lymphoma with blastic transformation

    E. Späth-Schwalbe, B. Flath, O. Kaufmann, G. Thiel, R. Brinckmann in Annals of Hematology (2000)

  14. No Access

    Article

    New therapeutic approaches in primary systemic AL amyloidosis

    O. Sezer, J. Eucker, P. Schmid, K. Possinger in Annals of Hematology (2000)

  15. No Access

    Article

    Eosinophilia during fludarabine treatment of chronic lymphocytic leukemia

     Although eosinophilia has been reported as a side effect of purine analogues, there is no report on fludarabine-induced eosinophilia in chronic lymphocytic leukemia (CLL). During chemotherapy with fludarabine...

    O. Sezer, P. Schmid, M. Hallek, M. Schweigert, T. Beinert in Annals of Hematology (1999)

  16. No Access

    Article

    Rapid reversal of nephrotic syndrome due to primary systemic AL amyloidosis after VAD and subsequent high-dose chemotherapy with autologous stem cell support

    In a patient with nephrotic syndrome, renal biopsy revealed AL amyloid deposits. Monoclonal λ light chains were identified in serum and urine. A low percentage of monoclonal plasma cells was detected in the bo...

    O Sezer, P Schmid, M Schweigert, U Heider, J Eucker in Bone Marrow Transplantation (1999)

  17. No Access

    Article

    Gemcitabine for palliative treatment in metastatic breast cancer

    Gemcitabine is one of the recently developed drugs with a high efficacy in various malignant tumours and a mild toxicity profile. As monochemotherapy in metastatic breast cancer, gemcitabine yielded response ...

    D. Lüftner, B. Flath, C. Akrivakis in Journal of Cancer Research and Clinical On… (1998)

  18. No Access

    Article

    Red cell aplasia and megakaryocytic hypoplasia with elevated counts of CD8-positive lymphocytes after resection of a thymoma responding to cyclosporine

    E. Späth-Schwalbe, R. Arnold, B. Flath, K. Possinger in Annals of Hematology (1998)

  19. Article

    Phase II studies of 1,2,4-triglycidyluracol (TGU) in solid tumors

    W. Queißer, H. -E. Wander, K. Possinger in Journal of Cancer Research and Clinical On… (1986)

  20. Article

    Influence of cytotoxic chemotherapy on survival in patients with metastatic breast cancer

    L. Jaspers, K. Possinger, W. Wilmanns in Journal of Cancer Research and Clinical On… (1986)

previous disabled Page of 2